149 related articles for article (PubMed ID: 38554186)
41. Development and validation of a nomogram to predict the prognosis of patients with gastric cardia cancer.
Shi X; Xu L; Ma B; Wang S
Sci Rep; 2020 Aug; 10(1):14143. PubMed ID: 32839498
[TBL] [Abstract][Full Text] [Related]
42. A novel analytic approach for outcome prediction in diffuse large B-cell lymphoma by [
Zhang X; Chen L; Jiang H; He X; Feng L; Ni M; Ma M; Wang J; Zhang T; Wu S; Zhou R; Jin C; Zhang K; Qian W; Chen Z; Zhuo C; Zhang H; Tian M
Eur J Nucl Med Mol Imaging; 2022 Mar; 49(4):1298-1310. PubMed ID: 34651227
[TBL] [Abstract][Full Text] [Related]
43. Identification of molecular subtypes and a novel prognostic model of diffuse large B-cell lymphoma based on a metabolism-associated gene signature.
He J; Chen Z; Xue Q; Sun P; Wang Y; Zhu C; Shi W
J Transl Med; 2022 Apr; 20(1):186. PubMed ID: 35468826
[TBL] [Abstract][Full Text] [Related]
44. [Development and Evaluation of Prognostic Nomogram Model for Adult Ventricle Glioma Patients].
Zhang HD; Niu XD; Zhou XW; Yang Y; Li JM; Gan YJ; Wang X; Liu YH; Mao Q
Sichuan Da Xue Xue Bao Yi Xue Ban; 2022 Jul; 53(4):588-596. PubMed ID: 35871728
[TBL] [Abstract][Full Text] [Related]
45. A Novel Prognostic Model for Patients with Primary Gastric Diffuse Large B-Cell Lymphoma.
Lu G; Lin Z; Ruan Y; Huang H; Lin J; Pan J
J Oncol; 2022; 2022():9636790. PubMed ID: 36339648
[TBL] [Abstract][Full Text] [Related]
46. Nomogram for Predicting the Overall Survival of Adult Patients With Primary Gastrointestinal Diffuse Large B Cell Lymphoma: A SEER- Based Study.
Wang J; Zhou M; Zhou R; Xu J; Chen B
Front Oncol; 2020; 10():1093. PubMed ID: 32719748
[No Abstract] [Full Text] [Related]
47. Establishment and validation of nomogram models for overall survival and cancer-specific survival in spindle cell sarcoma patients.
Qi W; Ren Y; Wang H; Wan Y; Wang D; Yao J; Pan H
Sci Rep; 2023 Dec; 13(1):23018. PubMed ID: 38155261
[TBL] [Abstract][Full Text] [Related]
48. Development and validation of a novel risk stratification model and a survival rate calculator for diffuse large B-cell lymphoma in the rituximab era: a multi-institutional cohort study.
Zhong Q; Chen H; Chen D; Qin Y; He X; Yang Y; Yang J; Liu P; Zhou S; Yang S; Zhou Y; Tang L; Chen C; Shi Y
Ann Hematol; 2024 Jan; 103(1):211-226. PubMed ID: 37861735
[TBL] [Abstract][Full Text] [Related]
49. Bladder cancer survival nomogram: Development and validation of a prediction tool, using the SEER and TCGA databases.
Zhang Y; Hong YK; Zhuang DW; He XJ; Lin ME
Medicine (Baltimore); 2019 Nov; 98(44):e17725. PubMed ID: 31689813
[TBL] [Abstract][Full Text] [Related]
50. Establishment of Prognosis Nomogram for Primary Splenic Diffuse Large B Cell Lymphoma: A Study Based on SEER Database.
Yonghao O; Yongyang W; Siqing Y; Chengchao F; Lihua C; Xin L; Shuju T
Indian J Hematol Blood Transfus; 2024 Apr; 40(2):220-230. PubMed ID: 38708154
[TBL] [Abstract][Full Text] [Related]
51. A novel lactate dehydrogenase-based risk score model to predict the prognosis of primary central nervous system germ cell tumor treated with chemoradiotherapy.
Yao DC; Ye BK; Yao DJ; Guo CC
Clin Neurol Neurosurg; 2024 Jan; 236():108081. PubMed ID: 38091701
[TBL] [Abstract][Full Text] [Related]
52. Screening of Adverse Prognostic Factors and Construction of Prognostic Index in Previously Untreated Concurrent Follicular Lymphoma and Diffuse Large B-Cell Lymphoma.
Qu Z; Zhang T; Gao F; Gong W; Cui Y; Qiu L; Qian Z; Zhou S; Meng B; Ren X; Li L; Wang X; Zhang H
Biomed Res Int; 2022; 2022():4379556. PubMed ID: 35655476
[TBL] [Abstract][Full Text] [Related]
53. Development and validation of prognostic nomogram for germ cell testicular cancer patients.
Mao W; Wu J; Kong Q; Li J; Xu B; Chen M
Aging (Albany NY); 2020 Nov; 12(21):22095-22111. PubMed ID: 33136554
[TBL] [Abstract][Full Text] [Related]
54. Construction and validation of a novel prognostic nomogram for predicting overall survival in lung adenocarcinoma patients with different patterns of metastasis.
Xiong Y; Gu F; Cui J; Liu Y; Sun M; Gu X; Zhong L; Zhang K; Liu L
J Cancer Res Clin Oncol; 2023 Nov; 149(16):15039-15053. PubMed ID: 37612389
[TBL] [Abstract][Full Text] [Related]
55. [Development and validation of prognostic nomogram for malignant pleural mesothelioma].
Xie XJ; Chen JY; Jiang J; Duan H; Wu Y; Zhang XW; Yang SJ; Zhao W; Shen SS; Wu L; He B; Ding YY; Luo H; Liu SY; Han D
Zhonghua Zhong Liu Za Zhi; 2023 May; 45(5):415-423. PubMed ID: 37188627
[No Abstract] [Full Text] [Related]
56. [Expression of MCP-1 and CCR2 in Newly Diagnosed Diffuse Large B-Cell Lymphoma and Clinical Significance].
Wang M; Zhang PP; Zhu Q; Hu ZL; Bai X; Wu YP; Li JJ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2024 Feb; 32(1):112-119. PubMed ID: 38387908
[TBL] [Abstract][Full Text] [Related]
57. Specific mortality in patients with diffuse large B-cell lymphoma: a retrospective analysis based on the surveillance, epidemiology, and end results database.
Xu H; Yan R; Ye C; Li J; Ji G
Eur J Med Res; 2024 Apr; 29(1):241. PubMed ID: 38643217
[TBL] [Abstract][Full Text] [Related]
58. Nomogram predicting overall survival of rectal squamous cell carcinomas patients based on the SEER database: A population-based STROBE cohort study.
Diao JD; Wu CJ; Cui HX; Bu MW; Yue D; Wang X; Liu YL; Yang YJ
Medicine (Baltimore); 2019 Nov; 98(46):e17916. PubMed ID: 31725640
[TBL] [Abstract][Full Text] [Related]
59. Prognostic nomogram for glioblastoma (GBM) patients presenting with distant extension: a seer-based study.
Zhou Z; Yuan J; Chen H; Zhan LP; Sun EY; Chen B
J Cancer Res Clin Oncol; 2023 Oct; 149(13):11595-11605. PubMed ID: 37401940
[TBL] [Abstract][Full Text] [Related]
60. Loss of 5-hydroxymethylcytosine as a Poor Prognostic Factor for Primary Testicular Diffuse Large B-cell Lymphoma.
Shen Y; Wang L; Ou J; Wang B; Cen X
Int J Med Sci; 2022; 19(2):225-232. PubMed ID: 35165508
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
